6/21/2013

The FDA has cleared Quidel to market its Sofia Strep A fluorescent immunoassay, which will run on the company's Sofia Analyzer. Group A streptococcus bacteria are often linked to bacterial pharyngitis and can trigger potentially dangerous conditions such as rheumatic fever.

Related Summaries